organization
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Also known as Global Fund, The Global Fund, GFATM
The Global Fund to Fight AIDS, Tuberculosis and Malaria, founded in 2002, says it is the largest multilateral funder of global health grants in low- and middle-income countries, investing more than US$4 billion a year.[1][2] It estimates that its partnership has saved 72 million lives since 2002.[3] Its Eighth Replenishment in November 2025 raised US$11.34 billion at the summit, short of its target, including US$4.6 billion from the United States.[4][5][6]
Key facts
The Global Fund to Fight AIDS, Tuberculosis and Malaria was founded in 2002 and began operations in January that year.[1] It is a partnership to defeat AIDS, tuberculosis and malaria. It says it raises and invests more than US$4 billion a year in more than 100 of the hardest-hit countries, and that it is the largest multilateral funder of global health grants in low- and middle-income countries, with more than US$73 billion disbursed since 2002.[2] About 94% of its money comes from donor governments; the rest comes from the private sector, foundations and innovative financing.[7] For the wider picture, see the infectious disease crash course.
This page describes an organisation and its funding. It is not medical advice; talk to a clinician about HIV, TB or malaria testing, prevention or treatment.
How the money flows
The Global Fund finances programmes but does not run them. It has no offices in the countries it supports: its staff are based in Geneva.[8] In each country a Country Coordinating Mechanism, a national committee that includes government, civil society, people living with the diseases and other sectors, writes the funding application and oversees the grants.[9] Every funding request is assessed for technical merit by an independent group of experts, the Technical Review Panel.[10]
Once a grant is running, the Global Fund relies on independent Local Fund Agents, generally one per country, to monitor it.[8] Its Office of the Inspector General audits and investigates its work. That office is independent of the Secretariat and reports directly to the Board through the Audit and Finance Committee.[11] The Board approves all funding decisions. It has 20 voting members, split equally between implementers and donors, and eight non-voting members, including representatives of WHO and the World Bank.[12]
The Global Fund also expects countries to pay more over time. Under its Sustainability, Transition and Co-Financing Policy, revised in 2024, part of each grant depends on the country meeting co-financing requirements.[13] Gavi, which supports vaccines in lower-income countries, also requires every country it supports to co-finance part of the cost.[14]
What it claims to have achieved
The Global Fund estimates that its partnership has saved 72 million lives since 2002 and cut the combined death rate from AIDS, TB and malaria by 65% in the countries where it invests.[3] These are modelled estimates. Programmes report their results to the Global Fund, which cross-checks them against technical partners’ data and measures coverage and impact against WHO and UNAIDS estimates.[15]
It says it provides 28% of all international financing for HIV programmes, 80% for TB and 57% for malaria; the malaria share uses 2024 data.[16] In its 2026 Results Report it says 26.9 million people were on antiretroviral therapy in 2025 in countries where it invests.[17] In those countries, 80% of people living with HIV were on treatment in 2025, up from 22% in 2010, and TB treatment coverage reached 79% in 2024, up from 44% in 2010.[18] Citing WHO estimates, it reports that TB deaths in those countries fell by 43% between 2002 and 2024.[19] In 2025 it supported the first rollout of the HIV prevention medicine lenacapavir in early-adopter countries.[20]
2025: cuts and disruption
The 2026 Results Report describes 2025 as a year of abrupt cuts in international health financing. It says funding disruptions affected HIV prevention programmes and community-led services, and that many countries reported stock-outs of essential malaria medicines.[21]
The Eighth Replenishment
The Global Fund raises money in three-year cycles called Replenishments, an approach it adopted in 2005. Each cycle starts with a preparatory meeting, where it presents an investment case, and ends with a pledging conference.[22]
The Eighth Replenishment Summit took place in Johannesburg on 21 November 2025. It was co-hosted by South Africa and the United Kingdom on the margins of the G20 summit, and donors pledged US$11.34 billion.[4] The Global Fund’s Investment Case had set a target of US$18 billion, and the Global Fund said the total fell short of it.[5] The Board later welcomed a final outcome of US$12.64 billion.[23]
The United States, the Global Fund’s largest donor, pledged US$4.6 billion, down from the US$6 billion it pledged in 2022.[6] KFF says US law caps US contributions at 33% of total donor contributions, and Health Policy Watch reported that the 2025 pledge is tied to a 1:2 match, with each US dollar matched by at least two dollars from other donors.[24] Other pledges included GBP 850 million from the United Kingdom, EUR 1 billion from Germany and CAD 1.02 billion from Canada.[25]
Read next
Gavi, the Vaccine Alliance
How Gavi pays for vaccines in lower-income countries: who runs it, how co-financing and eligibility work, its 2026-2030 strategy and the funding gap.
Questions readers ask
What does the Global Fund do?
It raises money from donors, mostly governments, and invests more than US$4 billion a year in HIV, tuberculosis and malaria programmes in more than 100 countries. It finances programmes but has no country offices; national committees apply for and oversee its grants.[2][7][8][9]
How much did the Global Fund raise in its latest replenishment?
Donors pledged US$11.34 billion at the Eighth Replenishment Summit in Johannesburg on 21 November 2025, short of the Investment Case target. The Global Fund's Board later welcomed a final outcome of US$12.64 billion.[4][5][23]
How much does the United States give?
The United States, the Global Fund's largest donor, pledged US$4.6 billion for the Eighth Replenishment, down from US$6 billion in 2022. KFF says US law caps its contribution at 33% of total donor contributions, and Health Policy Watch reported that the 2025 pledge requires each US dollar to be matched by at least two from other donors.[6][24]
How does the Global Fund check how its money is spent?
It relies on independent Local Fund Agents in each country to monitor grants, an independent Technical Review Panel to assess funding requests, and an Office of the Inspector General that audits and investigates and reports to the Board.[8][10][11]
Where do the Global Fund's results figures come from?
Programmes it supports report their results to it, and these are cross-checked against technical partners' data. Coverage and impact are measured against WHO and UNAIDS estimates.[15]
Sources
· 25 claims from 5 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
The Global Fund to Fight AIDS, Tuberculosis and Malaria was founded in 2002 and began operations in January that year. confirmedas of 2026-11-07
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [2]
The Global Fund, a partnership to defeat AIDS, TB and malaria, says it raises and invests more than US$4 billion a year in more than 100 of the hardest-hit countries, and is the largest multilateral funder of global health grants in low- and middle-income countries, having disbursed more than US$73 billion since 2002. confirmedas of 2026-11-07
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- [3]
The Global Fund estimates that its partnership has saved 72 million lives since 2002 and reduced the combined death rate from AIDS, TB and malaria by 65% in the countries where it invests. confirmedas of 2026-11-07
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- [4]
At the Global Fund's Eighth Replenishment Summit in Johannesburg on 21 November 2025, co-hosted by South Africa and the United Kingdom on the margins of the G20 summit, donors pledged US$11.34 billion. confirmedas of 2025-11-22
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- South Africa, UK raise US$11.34bn to boost fight against HIV, TB and Malaria · SAnews (South African Government News Agency) · Primary source · 2025-11-22 (retrieved 2026-11-07)
- [5]
The Global Fund's Investment Case set a US$18 billion target for the Eighth Replenishment, and the Global Fund said the pledges fell short of it. confirmedas of 2025-11-22
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Eighth Replenishment Investment Case: Summary · The Global Fund · Primary source · 2025-02-21 · Investment Case summary PDF, PDF page 7 (retrieved 2026-11-14)
- Global Fund raises $11.4 billion, including $4.6 billion from US · Health Policy Watch · Secondary source · 2025-11-21 (retrieved 2026-11-07)
- [6]
The United States, the Global Fund's largest donor, pledged US$4.6 billion at the Eighth Replenishment, down from the US$6 billion it pledged at the previous replenishment in 2022. confirmedas of 2025-11-22
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Global Fund raises $11.4 billion, including $4.6 billion from US · Health Policy Watch · Secondary source · 2025-11-21 (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [7]
About 94% of the Global Fund's funding comes from donor governments, with the rest from the private sector, foundations and innovative financing. confirmedas of 2026-11-07
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- [8]
The Global Fund has no offices in the countries it supports; its staff are based in Geneva, and it relies on independent Local Fund Agents, generally one per country, to monitor grants. confirmedas of 2026-11-07
- Local Fund Agents · The Global Fund · Primary source (retrieved 2026-11-07)
- Local Fund Agents · The Global Fund · Primary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [9]
Country Coordinating Mechanisms are national committees, including government, civil society, people living with the diseases and other sectors, that submit funding applications to the Global Fund and oversee grants. confirmedas of 2026-11-07
- Country Coordinating Mechanism · The Global Fund · Primary source (retrieved 2026-11-07)
- Country Coordinating Mechanism · The Global Fund · Primary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [10]
Every funding request to the Global Fund is evaluated for technical merit and strategic focus by an independent group of experts, the Technical Review Panel. confirmedas of 2026-11-07
- Technical Review Panel · The Global Fund · Primary source (retrieved 2026-11-07)
- [11]
The Global Fund's Office of the Inspector General audits and investigates its activities, is independent of the Secretariat, and reports directly to the Board through its Audit and Finance Committee. confirmedas of 2026-11-07
- Office of the Inspector General · The Global Fund · Primary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [12]
The Global Fund Board approves all funding decisions and has 20 voting members, split equally between implementers and donors, plus eight non-voting members including representatives of WHO and the World Bank. confirmedas of 2026-11-07
- Board · The Global Fund · Primary source (retrieved 2026-11-07)
- About the Global Fund · The Global Fund · Primary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- [13]
Under its Sustainability, Transition and Co-Financing Policy, revised in 2024, the Global Fund makes a portion of its grants contingent on countries meeting co-financing requirements. confirmedas of 2026-11-07
- Sustainability, Transition and Co-financing · The Global Fund · Primary source (retrieved 2026-11-07)
- Sustainability, Transition and Co-financing · The Global Fund · Primary source (retrieved 2026-11-07)
- [14]
All countries receiving Gavi vaccine support must co-finance part of the cost; in the initial self-financing phase the contribution is a flat US$0.20 per dose for most routine vaccines, and in the preparatory transition phase it rises by 15% a year. confirmedas of 2026-11-07
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- Co-financing policy · Gavi, the Vaccine Alliance · Primary source (retrieved 2026-11-07)
- [15]
The Global Fund's programmatic results are reported by the programmes it supports and cross-checked against data from technical partners, while coverage and impact are measured against WHO and UNAIDS estimates. confirmedas of 2026-09-30
- [17]
The Global Fund reports that 26.9 million people were on antiretroviral therapy in 2025 in countries where it invests. confirmedas of 2026-09-30
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- [18]
In countries where the Global Fund invests, 80% of people living with HIV were receiving antiretroviral therapy in 2025, up from 22% in 2010, and TB treatment coverage reached 79% in 2024, up from 44% in 2010. confirmedas of 2026-09-30
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- [19]
- [20]
In 2025 the Global Fund supported the first rollout of the HIV prevention medicine lenacapavir in early-adopter countries. confirmedas of 2026-09-30
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- [21]
The Global Fund's 2026 Results Report describes 2025 as a year of abrupt cuts in international health financing; it says funding disruptions affected HIV prevention programmes and community-led services, and that many countries reported stock-outs of essential malaria medicines. confirmedas of 2026-09-30
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- Results · The Global Fund · Primary source (retrieved 2026-11-07)
- [22]
The Global Fund raises money in three-year cycles called Replenishments, an approach adopted in 2005 after its first years of ad hoc donations; each cycle has a preparatory meeting with an investment case followed by a pledging conference. confirmedas of 2026-11-07
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- [23]
The Global Fund's Board later welcomed a final Eighth Replenishment outcome of US$12.64 billion. confirmedas of 2026-11-07
- Eighth Replenishment · The Global Fund · Primary source (retrieved 2026-11-07)
- [24]
KFF says US law caps US contributions at 33% of total donor contributions to the Global Fund; Health Policy Watch reported that the 2025 US pledge is tied to a 1:2 match, with every US dollar matched by at least two dollars from other donors. reportedas of 2025-11-22
- The U.S. & the Global Fund to Fight AIDS, Tuberculosis and Malaria · KFF · Secondary source (retrieved 2026-11-07)
- Global Fund raises $11.4 billion, including $4.6 billion from US · Health Policy Watch · Secondary source · 2025-11-21 (retrieved 2026-11-07)
- [25]
Other Eighth Replenishment pledges included GBP 850 million from the United Kingdom, EUR 1 billion from Germany and CAD 1.02 billion from Canada. confirmedas of 2025-11-22
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Global Fund partners demonstrate unity and resolve to sustain progress and strengthen global health security · The Global Fund · Primary source · 2025-11-21 (retrieved 2026-11-07)
- Global Fund raises $11.4 billion, including $4.6 billion from US · Health Policy Watch · Secondary source · 2025-11-21 (retrieved 2026-11-07)
Revision history (3)
- Attributed the US 33% cap to KFF and the 1:2 match to Health Policy Watch.
- Sourced the US$18 billion replenishment target to the Global Fund's own Investment Case.
- Page created.
Created Nov 8, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.
Cite this page
"The Global Fund to Fight AIDS, Tuberculosis and Malaria." ContentLora, updated Nov 14, 2026. https://contentlora.com/wiki/global-fund
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.